You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Finalists invited to pitch ideas to panel of judges including Robert Herjavec, technology entrepreneur, passionate cancer caregiver and star of ABC's Emmy Award-winning hit television show Shark Tank
NORTHBROOK, Ill., April 25, 2016 /PRNewswire/ -- Astellas today announced key leadership appointments in its Ethics and Compliance and US Legal departments, taking effect April 25. Mark Wanda will...
NORTHBROOK, Ill., April 7, 2016 /PRNewswire/ -- Astellas today named Bob Chib and Cassie Hogenkamp to key leadership roles within its Corporate Development function to advance the strategic...
Read more about Astellas Announces Key Leadership Appointments in Corporate Development
NORTHBROOK, Ill., April 6, 2016 /PRNewswire/ -- Astellas recently announced that Joseph Fleishaker, Ph.D., has been named vice president, Clinical Pharmacology and Exploratory Development....
Contact Tyler Marciniak Corporate Affairs Director 847-736-7145 tyler.marciniak@astellas.com XTANDI is a standard of care for advanced prostate cancer in the United States and widely available as...
Read more about Statement from Astellas regarding availability of XTANDI -- March 29, 2016
Follow U.S. news
